Competitive Dynamics and Strategic Developments in the Middle EAST Pranlukast Market
The Middle EAST Pranlukast Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.45 billion by 2034, registering a CAGR of 12.0%. This growth trajectory is underpinned by several factors, including the rising prevalence of respiratory diseases, increased awareness about asthma management, and the growing adoption of Pranlukast as a first-line treatment option. The demand...
0 Comments 0 Shares 44 Views 0 Reviews
SocioMint https://sociomint.com